Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Gains from Investment Securities (2023 - 2025)

Historic Gains from Investment Securities for Medical Group Holdings (SBC) over the last 3 years, with Q3 2025 value amounting to $17.9 million.

  • Medical Group Holdings' Gains from Investment Securities rose 1834.32% to $17.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.5 million, marking a year-over-year decrease of 28.4%. This contributed to the annual value of $30.2 million for FY2024, which is 6947.83% up from last year.
  • Medical Group Holdings' Gains from Investment Securities amounted to $17.9 million in Q3 2025, which was up 1834.32% from -$939836.0 recorded in Q2 2025.
  • Medical Group Holdings' 5-year Gains from Investment Securities high stood at $20.6 million for Q1 2025, and its period low was -$1.1 million during Q4 2024.
  • Moreover, its 3-year median value for Gains from Investment Securities was $10.2 million (2023), whereas its average is $9.1 million.
  • Within the past 5 years, the most significant YoY rise in Medical Group Holdings' Gains from Investment Securities was 2723.61% (2025), while the steepest drop was 513879.48% (2025).
  • Over the past 3 years, Medical Group Holdings' Gains from Investment Securities (Quarter) stood at $5.2 million in 2023, then plummeted by 120.88% to -$1.1 million in 2024, then skyrocketed by 1739.19% to $17.9 million in 2025.
  • Its Gains from Investment Securities stands at $17.9 million for Q3 2025, versus -$939836.0 for Q2 2025 and $20.6 million for Q1 2025.